Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate
Tuberculosis (TB) remains a major public health problem worldwide. Nearly one-third of the world population is latently infected with Mycobacterium tuberculosis (MTB) and 5 - 10 % of infected individuals will develop active disease during their life time. Bacille Calmette–Guérin (BCG) efficiently pr...
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.usm.my/43103/1/Dr._Mohd_Zakuan_Ismail-24_pages.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my-usm-ep.43103 |
---|---|
record_format |
uketd_dc |
spelling |
my-usm-ep.431032019-04-12T05:25:00Z Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate 2017-06 Ismail, Mohd Zakuan RC705-779 Diseases of the respiratory system Tuberculosis (TB) remains a major public health problem worldwide. Nearly one-third of the world population is latently infected with Mycobacterium tuberculosis (MTB) and 5 - 10 % of infected individuals will develop active disease during their life time. Bacille Calmette–Guérin (BCG) efficiently protects against severe disease manifestations in children, but does not prevent the establishment of latent TB or reactivation of TB pulmonary disease in adult life. Therefore, in order to control this scourge from exacerbating, the development of an effective TB vaccine is an urgent priority. The expression of MTB antigens in Mycobacterium smegmatis (MS) is one of the potential strategies for the development of new generation vaccines against TB. This study focused on the construction and evaluation of immunogenicity in Balb/C mice of a recombinant MS (rMS) expressing B- and T-cell epitopes of Latency-Associated Antigens (LAA) (Rv2005c, Rv2031c, Rv3130c, Rv3127) of MTB (rMS081). The capacity of rMS081 to induce specific humoral and cellular immune responses against expressed B- and T-cell epitopes was evaluated. Total specific Immunoglobulin G (IgG) showed a significant increase against all epitopes (Rv2005c, Rv2031c, Rv3130c, Rv3127) in the sera of rMS081-immunized mice compared with the control group. In the experimental conditions evaluated, there were no significant increase in the cytokines, Interferon-gamma (IFN-), Interleukin (IL)-2 and IL-4 against the LAA epitopes in the rMS081-immunized mice compared with the control group. The results obtained support the future evaluation of rMS081 as a vaccine candidate against TB in challenge studies. 2017-06 Thesis http://eprints.usm.my/43103/ http://eprints.usm.my/43103/1/Dr._Mohd_Zakuan_Ismail-24_pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan |
institution |
Universiti Sains Malaysia |
collection |
USM Institutional Repository |
language |
English |
topic |
RC705-779 Diseases of the respiratory system |
spellingShingle |
RC705-779 Diseases of the respiratory system Ismail, Mohd Zakuan Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
description |
Tuberculosis (TB) remains a major public health problem worldwide. Nearly one-third of the world population is latently infected with Mycobacterium tuberculosis (MTB) and 5 - 10 % of infected individuals will develop active disease during their life time. Bacille Calmette–Guérin (BCG) efficiently protects against severe disease manifestations in children, but does not prevent the establishment of latent TB or reactivation of TB pulmonary disease in adult life. Therefore, in order to control this scourge from exacerbating, the development of an effective TB vaccine is an urgent priority. The expression of MTB antigens in Mycobacterium smegmatis (MS) is one of the potential strategies for the development of new generation vaccines against TB. This study focused on the construction and evaluation of immunogenicity in Balb/C mice of a recombinant MS (rMS) expressing B- and T-cell epitopes of Latency-Associated Antigens (LAA) (Rv2005c, Rv2031c, Rv3130c, Rv3127) of MTB (rMS081). The capacity of rMS081 to induce specific humoral and cellular immune responses against expressed B- and T-cell epitopes was evaluated. Total specific Immunoglobulin G (IgG) showed a significant increase against all epitopes (Rv2005c, Rv2031c, Rv3130c, Rv3127) in the sera of rMS081-immunized mice compared with the control group. In the experimental conditions evaluated, there were no significant increase in the cytokines, Interferon-gamma (IFN-), Interleukin (IL)-2 and IL-4 against the LAA epitopes in the rMS081-immunized mice compared with the control group. The results obtained support the future evaluation of rMS081 as a vaccine candidate against TB in challenge studies. |
format |
Thesis |
qualification_level |
Master's degree |
author |
Ismail, Mohd Zakuan |
author_facet |
Ismail, Mohd Zakuan |
author_sort |
Ismail, Mohd Zakuan |
title |
Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
title_short |
Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
title_full |
Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
title_fullStr |
Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
title_full_unstemmed |
Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate |
title_sort |
development of recombinant mycobacterium smegmatis (ms) expressing b- and t-cell epitopes of latency associated antigens of mycobacterium tuberculosis (mtb) as a tb vaccine candidate |
granting_institution |
Universiti Sains Malaysia |
granting_department |
Pusat Pengajian Sains Perubatan |
publishDate |
2017 |
url |
http://eprints.usm.my/43103/1/Dr._Mohd_Zakuan_Ismail-24_pages.pdf |
_version_ |
1747821164766429184 |